JPS4938268B1 - - Google Patents

Info

Publication number
JPS4938268B1
JPS4938268B1 JP2278168A JP2278168A JPS4938268B1 JP S4938268 B1 JPS4938268 B1 JP S4938268B1 JP 2278168 A JP2278168 A JP 2278168A JP 2278168 A JP2278168 A JP 2278168A JP S4938268 B1 JPS4938268 B1 JP S4938268B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2278168A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4938268B1 publication Critical patent/JPS4938268B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2278168A 1967-06-14 1968-04-06 Pending JPS4938268B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2738267 1967-06-14
GB3759867 1967-08-16

Publications (1)

Publication Number Publication Date
JPS4938268B1 true JPS4938268B1 (enExample) 1974-10-16

Family

ID=26258780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2278168A Pending JPS4938268B1 (enExample) 1967-06-14 1968-04-06

Country Status (15)

Country Link
JP (1) JPS4938268B1 (enExample)
BE (1) BE713392A (enExample)
CH (1) CH560204A5 (enExample)
DE (1) DE1770177A1 (enExample)
DK (1) DK137674B (enExample)
ES (1) ES352579A1 (enExample)
FR (2) FR8056M (enExample)
GB (1) GB1226548A (enExample)
IE (1) IE32086B1 (enExample)
IL (1) IL29654A (enExample)
IT (1) IT1053686B (enExample)
LU (1) LU55869A1 (enExample)
NL (1) NL6805103A (enExample)
PL (1) PL71145B1 (enExample)
SE (1) SE374745B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009586A1 (en) * 1990-11-30 1992-06-11 Otsuka Pharmaceutical Co., Ltd. Active oxygen inhibitor

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794096A (fr) * 1972-08-07 1973-05-16 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
JPS58183676A (ja) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd オキサゾ−ル誘導体
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009586A1 (en) * 1990-11-30 1992-06-11 Otsuka Pharmaceutical Co., Ltd. Active oxygen inhibitor

Also Published As

Publication number Publication date
GB1226548A (enExample) 1971-03-31
BE713392A (enExample) 1968-10-08
CH560204A5 (enExample) 1975-03-27
ES352579A1 (es) 1970-01-01
DE1770177A1 (de) 1972-03-16
SE374745B (enExample) 1975-03-17
IL29654A (en) 1974-05-16
DK137674C (enExample) 1978-09-25
PL71145B1 (en) 1974-04-30
IT1053686B (it) 1981-10-10
IE32086L (en) 1968-12-14
FR1587052A (enExample) 1970-03-13
FR8056M (enExample) 1970-07-06
IE32086B1 (en) 1973-04-04
NL6805103A (enExample) 1968-12-16
LU55869A1 (enExample) 1968-07-09
DK137674B (da) 1978-04-17

Similar Documents

Publication Publication Date Title
FR1587052A (enExample)
AU2116667A (enExample)
BE705831A (enExample)
BE709588A (enExample)
BE702787A (enExample)
BE711661A (enExample)
BE703990A (enExample)
BE709642A (enExample)
BE707395A (enExample)
BE710181A (enExample)
BE704927A (enExample)
BE708424A (enExample)
BE696728A (enExample)
BE708627A (enExample)
BE705081A (enExample)
BE709263A (enExample)
BE708670A (enExample)
BE709608A (enExample)
BE708650A (enExample)
BE707508A (enExample)
BE700981A (enExample)
BE708972A (enExample)
BE709005A (enExample)
BE707955A (enExample)
BE704533A (enExample)